ID Biomedical posts wider Q2 loss of $32.5M compared to year-ago $10.9M

VANCOUVER (CP) - ID Biomedical Corp. said Monday a much anticipated deal with the Canadian government for the funding of clinical trials of pandemic mock influenza vaccine should be signed "shortly....More